# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Neuromyelitis Optica
- **MONDO ID:**  (if available)
- **Category:** Neurological Disorder

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Neuromyelitis Optica**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** perplexity
**Generated:** 2026-02-01T09:19:49.768923

1. https://eyewiki.org/Neuromyelitis_Optica
2. https://en.wikipedia.org/wiki/Neuromyelitis_optica_spectrum_disorder
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC3678971/
4. https://www.ncbi.nlm.nih.gov/books/NBK572108/
5. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.959469/full
6. https://www.mayocliniclabs.com/test-catalog/overview/38324
7. https://pmc.ncbi.nlm.nih.gov/articles/PMC6198534/
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC10011114/
9. https://pmc.ncbi.nlm.nih.gov/articles/PMC9006458/
10. https://www.science.org/doi/abs/10.1126/sciadv.adq7560
11. https://eyewiki.org/Myelin_Oligodendrocyte_Glycoprotein_(MOG)_Optic_Neuritis
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC3068006/
13. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1635989/full
14. https://pmc.ncbi.nlm.nih.gov/articles/PMC12511702/
15. https://www.neurology.org/doi/10.1212/NXI.0000000000000343
16. https://pmc.ncbi.nlm.nih.gov/articles/PMC8444436/
17. https://www.rarediseaseadvisor.com/hcp-resource/neuromyelitis-optica-spectrum-disorder-genetics/
18. https://pubmed.ncbi.nlm.nih.gov/26656646/
19. https://pmc.ncbi.nlm.nih.gov/articles/PMC8364446/
20. https://onlinelibrary.wiley.com/doi/full/10.1111/1756-185X.14973
21. https://onlinelibrary.wiley.com/doi/10.1111/cen3.70019
22. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2017.00062/full
23. https://pmc.ncbi.nlm.nih.gov/articles/PMC6406241/
24. https://pmc.ncbi.nlm.nih.gov/articles/PMC7919716/
25. https://www.cuba.dialogoroche.com/content/dam/roche-dialogo/global-assets/downloadable-assets/neurology/neuromielitis-%C3%B3ptica/pathophysiology_of_nmosd_and_the_role_of_Il6.pdf
26. https://pmc.ncbi.nlm.nih.gov/articles/PMC6352324/
27. https://www.journalofneuropsychiatry.cl/docs/5/29.pdf
28. https://pmc.ncbi.nlm.nih.gov/articles/PMC6971496/
29. https://pmc.ncbi.nlm.nih.gov/articles/PMC7431838/
30. https://pmc.ncbi.nlm.nih.gov/articles/PMC10397275/
31. https://pmc.ncbi.nlm.nih.gov/articles/PMC6397677/
32. https://www.neurologylive.com/view/progression-of-nmosd-over-time
33. https://clinicalinsightsineyecare.scholasticahq.com/article/129966-case-report-successful-visual-recovery-in-neuromyelitis-optica-spectrum-disorder
34. https://www.physio-pedia.com/Neuromyelitis_Optica
35. https://pmc.ncbi.nlm.nih.gov/articles/PMC11476930/
36. https://pmc.ncbi.nlm.nih.gov/articles/PMC12835373/
37. https://faseb.onlinelibrary.wiley.com/doi/10.1096/fj.09-141978
38. https://ragoninstitute.org/2025/02/new-study-reveals-how-regulatory-t-cells-prevent-autoimmune-attacks-without-weakening-immunity/
39. https://www.rarediseaseadvisor.com/disease-info-pages/neuromyelitis-optica-spectrum-disorder-treatment/
40. https://www.neurology.org/doi/10.1212/NXI.0000000000000727
41. https://pmc.ncbi.nlm.nih.gov/articles/PMC9166560/
42. https://pmc.ncbi.nlm.nih.gov/articles/PMC8490892/
43. https://pmc.ncbi.nlm.nih.gov/articles/PMC8983882/
44. https://pmc.ncbi.nlm.nih.gov/articles/PMC9323454/
45. https://pmc.ncbi.nlm.nih.gov/articles/PMC5177679/
46. https://pmc.ncbi.nlm.nih.gov/articles/PMC4371410/
47. https://pmc.ncbi.nlm.nih.gov/articles/PMC11319236/
48. https://www.neurology.org/doi/10.1212/WNL.0000000000201465
49. https://www.rarediseaseadvisor.com/insights/shedding-light-double-negative-nmosd/
50. https://academic.oup.com/brain/article/145/1/64/6367770
51. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073970/
52. https://pmc.ncbi.nlm.nih.gov/articles/PMC10580671/